Dantrolene Sodium Capsule
Product Images NDC 0904-7211

2 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dantrolene Sodium (NDC 0904-7211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (90414d2f 7b2c 47f9 A096 2e7b7dd052de 00)

Carton Label (90414d2f 7b2c 47f9 A096 2e7b7dd052de 00)
Dantrolene Sodium Capsules, USP 25 mg oral capsule unit dose packaging label from Major Pharmaceuticals. The label includes the proprietary and generic name, strength (25 mg), indication as peripheral skeletal muscle relaxant, Rx only status, and package quantity of 30 capsules. It also lists manufacturer information and handling instructions.*
FDA Label Image

Chemical Structure (Dantrolene Sodium Capsules 1)

Chemical Structure (Dantrolene Sodium Capsules 1)
Chemical structure of Dantrolene Sodium showing the molecular arrangement including aromatic rings, nitro groups, and sodium salt with hydration indicated as 3.5 water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.